Levodopa in the treatment of Parkinson's disease: Current controversies
Identifieur interne : 003865 ( Main/Exploration ); précédent : 003864; suivant : 003866Levodopa in the treatment of Parkinson's disease: Current controversies
Auteurs : Manfred Gerlach [Allemagne] ; Heinz Reichmann [Allemagne] ; Peter Riederer [Allemagne]Source :
- Movement Disorders [ 0885-3185 ] ; 2005-05.
English descriptors
- KwdEn :
- Animals, Antiparkinson Agents (adverse effects), Antiparkinson Agents (therapeutic use), Apomorphine (therapeutic use), Disease Models, Animal, Drug Therapy, Combination, Dyskinesia, Drug-Induced (etiology), Haplorhini, Levodopa (adverse effects), Levodopa (therapeutic use), Lisuride (therapeutic use), Parkinson Disease (drug therapy), Pergolide (therapeutic use).
- MESH :
- chemical , adverse effects : Antiparkinson Agents, Levodopa.
- chemical , therapeutic use : Antiparkinson Agents, Apomorphine, Levodopa, Lisuride, Pergolide.
- drug therapy : Parkinson Disease.
- etiology : Dyskinesia, Drug-Induced.
- Animals, Disease Models, Animal, Drug Therapy, Combination, Haplorhini.
Abstract
Companion letters have been published in Movement Disorders: Current Controversies: Levodopa in the Treatment of Parkinson's Disease, by Sharma, Vassallo, and Ross and Reply: Levodopa in the Treatment of Parkinson's Disease, by Olanow, Agid, and Mizuno.
Url:
DOI: 10.1002/mds.20435
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 004107
- to stream Istex, to step Curation: 004107
- to stream Istex, to step Checkpoint: 002273
- to stream PubMed, to step Corpus: 003125
- to stream PubMed, to step Curation: 003125
- to stream PubMed, to step Checkpoint: 003078
- to stream Ncbi, to step Merge: 001176
- to stream Ncbi, to step Curation: 001176
- to stream Ncbi, to step Checkpoint: 001176
- to stream Main, to step Merge: 004F50
- to stream Main, to step Curation: 003865
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Levodopa in the treatment of Parkinson's disease: Current controversies</title><author><name sortKey="Gerlach, Manfred" sort="Gerlach, Manfred" uniqKey="Gerlach M" first="Manfred" last="Gerlach">Manfred Gerlach</name></author><author><name sortKey="Reichmann, Heinz" sort="Reichmann, Heinz" uniqKey="Reichmann H" first="Heinz" last="Reichmann">Heinz Reichmann</name></author><author><name sortKey="Riederer, Peter" sort="Riederer, Peter" uniqKey="Riederer P" first="Peter" last="Riederer">Peter Riederer</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:D0B2AA6DC94D82AA6EF9A8F29F3DF276E5B553C4</idno><date when="2005" year="2005">2005</date><idno type="doi">10.1002/mds.20435</idno><idno type="url">https://api.istex.fr/document/D0B2AA6DC94D82AA6EF9A8F29F3DF276E5B553C4/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">004107</idno><idno type="wicri:Area/Istex/Curation">004107</idno><idno type="wicri:Area/Istex/Checkpoint">002273</idno><idno type="wicri:doubleKey">0885-3185:2005:Gerlach M:levodopa:in:the</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:15732130</idno><idno type="wicri:Area/PubMed/Corpus">003125</idno><idno type="wicri:Area/PubMed/Curation">003125</idno><idno type="wicri:Area/PubMed/Checkpoint">003078</idno><idno type="wicri:Area/Ncbi/Merge">001176</idno><idno type="wicri:Area/Ncbi/Curation">001176</idno><idno type="wicri:Area/Ncbi/Checkpoint">001176</idno><idno type="wicri:doubleKey">0885-3185:2005:Gerlach M:levodopa:in:the</idno><idno type="wicri:Area/Main/Merge">004F50</idno><idno type="wicri:Area/Main/Curation">003865</idno><idno type="wicri:Area/Main/Exploration">003865</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Levodopa in the treatment of Parkinson's disease: Current controversies</title><author><name sortKey="Gerlach, Manfred" sort="Gerlach, Manfred" uniqKey="Gerlach M" first="Manfred" last="Gerlach">Manfred Gerlach</name><affiliation wicri:level="1"><country wicri:rule="url">Allemagne</country></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Division of Clinical Neurochemistry, Department of Child and Adolescent Psychiatry and Psychotherapy, Bayerische Julius‐Maximilians‐Universität, Würzburg</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden</wicri:regionArea><placeName><region type="land" nuts="1">Saxe (Land)</region><region type="district" nuts="2">District de Dresde</region><settlement type="city">Dresde</settlement></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Division of Clinical Neurochemistry, Department of Psychiatry and Psychotherapy, Bayerische Julius‐Maximilians‐Universität, Würzburg</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation></author><author><name sortKey="Reichmann, Heinz" sort="Reichmann, Heinz" uniqKey="Reichmann H" first="Heinz" last="Reichmann">Heinz Reichmann</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Division of Clinical Neurochemistry, Department of Child and Adolescent Psychiatry and Psychotherapy, Bayerische Julius‐Maximilians‐Universität, Würzburg</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden</wicri:regionArea><placeName><region type="land" nuts="1">Saxe (Land)</region><region type="district" nuts="2">District de Dresde</region><settlement type="city">Dresde</settlement></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Division of Clinical Neurochemistry, Department of Psychiatry and Psychotherapy, Bayerische Julius‐Maximilians‐Universität, Würzburg</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation></author><author><name sortKey="Riederer, Peter" sort="Riederer, Peter" uniqKey="Riederer P" first="Peter" last="Riederer">Peter Riederer</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Division of Clinical Neurochemistry, Department of Child and Adolescent Psychiatry and Psychotherapy, Bayerische Julius‐Maximilians‐Universität, Würzburg</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden</wicri:regionArea><placeName><region type="land" nuts="1">Saxe (Land)</region><region type="district" nuts="2">District de Dresde</region><settlement type="city">Dresde</settlement></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Division of Clinical Neurochemistry, Department of Psychiatry and Psychotherapy, Bayerische Julius‐Maximilians‐Universität, Würzburg</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2005-05">2005-05</date><biblScope unit="vol">20</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="643">643</biblScope><biblScope unit="page" to="643">643</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">D0B2AA6DC94D82AA6EF9A8F29F3DF276E5B553C4</idno><idno type="DOI">10.1002/mds.20435</idno><idno type="ArticleID">MDS20435</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Antiparkinson Agents (adverse effects)</term><term>Antiparkinson Agents (therapeutic use)</term><term>Apomorphine (therapeutic use)</term><term>Disease Models, Animal</term><term>Drug Therapy, Combination</term><term>Dyskinesia, Drug-Induced (etiology)</term><term>Haplorhini</term><term>Levodopa (adverse effects)</term><term>Levodopa (therapeutic use)</term><term>Lisuride (therapeutic use)</term><term>Parkinson Disease (drug therapy)</term><term>Pergolide (therapeutic use)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term><term>Levodopa</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term><term>Apomorphine</term><term>Levodopa</term><term>Lisuride</term><term>Pergolide</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dyskinesia, Drug-Induced</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Disease Models, Animal</term><term>Drug Therapy, Combination</term><term>Haplorhini</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Companion letters have been published in Movement Disorders: Current Controversies: Levodopa in the Treatment of Parkinson's Disease, by Sharma, Vassallo, and Ross and Reply: Levodopa in the Treatment of Parkinson's Disease, by Olanow, Agid, and Mizuno.</div></front></TEI><affiliations><list><country><li>Allemagne</li></country><region><li>Bavière</li><li>District de Basse-Franconie</li><li>District de Dresde</li><li>Saxe (Land)</li></region><settlement><li>Dresde</li><li>Wurtzbourg</li></settlement></list><tree><country name="Allemagne"><noRegion><name sortKey="Gerlach, Manfred" sort="Gerlach, Manfred" uniqKey="Gerlach M" first="Manfred" last="Gerlach">Manfred Gerlach</name></noRegion><name sortKey="Gerlach, Manfred" sort="Gerlach, Manfred" uniqKey="Gerlach M" first="Manfred" last="Gerlach">Manfred Gerlach</name><name sortKey="Gerlach, Manfred" sort="Gerlach, Manfred" uniqKey="Gerlach M" first="Manfred" last="Gerlach">Manfred Gerlach</name><name sortKey="Gerlach, Manfred" sort="Gerlach, Manfred" uniqKey="Gerlach M" first="Manfred" last="Gerlach">Manfred Gerlach</name><name sortKey="Reichmann, Heinz" sort="Reichmann, Heinz" uniqKey="Reichmann H" first="Heinz" last="Reichmann">Heinz Reichmann</name><name sortKey="Reichmann, Heinz" sort="Reichmann, Heinz" uniqKey="Reichmann H" first="Heinz" last="Reichmann">Heinz Reichmann</name><name sortKey="Reichmann, Heinz" sort="Reichmann, Heinz" uniqKey="Reichmann H" first="Heinz" last="Reichmann">Heinz Reichmann</name><name sortKey="Riederer, Peter" sort="Riederer, Peter" uniqKey="Riederer P" first="Peter" last="Riederer">Peter Riederer</name><name sortKey="Riederer, Peter" sort="Riederer, Peter" uniqKey="Riederer P" first="Peter" last="Riederer">Peter Riederer</name><name sortKey="Riederer, Peter" sort="Riederer, Peter" uniqKey="Riederer P" first="Peter" last="Riederer">Peter Riederer</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003865 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003865 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:D0B2AA6DC94D82AA6EF9A8F29F3DF276E5B553C4
|texte= Levodopa in the treatment of Parkinson's disease: Current controversies
}}
| This area was generated with Dilib version V0.6.23. |  |